Nils Siegbahn PhD, MBA, has vast experience from executive functions in pharma and medtech industry, such as KabiPharmacia Group, Perstorp AB, Atos Medical AB, Pernovo AB, Alligator Bioscience AB and Niconovum AB. He is currently engaged as board member in Sparbankstiftelsen I Syd Riskkapitalstiftelse and Celltrix AB, and previously as chairman of the board in Glycorex Transplantaion AB, Prosthetic Foot Co.
Nils Siegbahn
Chairman of the Board
Jan Nilsson
Board member
MBA, M.Sc. Formerly C.E.O of NeuroVive Pharmaceutical AB and G.M. of Schering-Plough AB. Has 30 years of drug industry experience, with several executive positions in marketing and corporate management.
Gregory Batcheller
Board member
Gregory Batcheller has a strong backgrond in emerging life science and pharmaceutical company development. He holds a JD from University of Toronto and a LLM from Lund University, Sweden. Greg is an accomplished dealmaker and has successfully negotiated many international licensing and M&A deals in Europe, the U.S., and China. Current assignmets are Chairman of the Board of Xintela AB, Saga Diagnostics AB, Monocl AB, Immune Biotech Medical Sweden AB and CarryGenes Therapeutics AB.
Lars Karlsson
Board member
Lars Karlsson MD, PhD, has extensive experience in drug discovery and development from senior positions at Johnson & Johnson, Regulus Therapeutics, Novo Nordisk, Silence Therapeutics, and Ferring Pharmaceuticals. He has expertise in immunology, pharmacology and translational science.